-+undefined NaN%
-+undefined NaN%
-+undefined NaN%

BRIEF-Biondvax’S Innovative Inhaled Covid-19 Therapy Virtually Eliminates Sars-Cov-2 Virus In Preclinical Study

Reuters · 01/06/2023 07:15
BRIEF-Biondvax’S Innovative Inhaled Covid-19 Therapy Virtually Eliminates Sars-Cov-2 Virus In Preclinical Study

- BiondVax Pharmaceuticals Ltd 2F50y.F:

  • BIONDVAX’S INNOVATIVE INHALED COVID-19 THERAPY VIRTUALLY ELIMINATED SARS-COV-2 VIRUS IN PRECLINICAL IN VIVO STUDY

  • BIONDVAX PHARMACEUTICALS LTD - FIRST-IN-HUMAN PHASE 1/2A CLINICAL TRIAL PLANNED FOR 2023

Source text for Eikon: ID:

Further company coverage: [2F50y.F]


((Reuters.Briefs@thomsonreuters.com;))